Literature DB >> 26716860

Process Evaluation of the Nationwide Implementation of a Lifestyle Intervention in the Construction Industry.

Susanne C Tonnon1, Karin I Proper, Hidde P van der Ploeg, Johannes R Anema, Allard J van der Beek.   

Abstract

OBJECTIVE: The aim of this study was to monitor the national scale up of the effective lifestyle intervention Health Under Construction in the Dutch construction industry.
METHODS: Data were collected on seven process indicators, ie, reach, dose delivered, dose received, fidelity, competence, satisfaction, and barriers.
RESULTS: The intervention reached 2.4% of the target group. Thirty-eight percent of the participants received five to seven consultations and 41% discussed all six intervention components. None of the counselors attained motivational interviewing proficiency. Participants perceived their counselor as competent and were satisfied with the intervention. Counselors were moderately satisfied with the intervention and experienced various barriers.
CONCLUSIONS: Even though important conditions for scale up were met, the implementation was characterized by a low reach, a high drop-out rate, and a low quality of the counseling technique.

Entities:  

Mesh:

Year:  2016        PMID: 26716860     DOI: 10.1097/JOM.0000000000000628

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  A multimedia campaign to improve back beliefs in patients with non-specific low back pain: a process evaluation.

Authors:  Arnela Suman; Frederieke G Schaafsma; Jiman Bamarni; Maurits W van Tulder; Johannes R Anema
Journal:  BMC Musculoskelet Disord       Date:  2017-05-18       Impact factor: 2.362

2.  Implementation Evaluation of a Cluster Randomized Controlled Trial to Promote the Use of Respiratory Protective Equipment Among Migrant Workers Exposed to Organic Solvents in Small and Medium-Sized Enterprises.

Authors:  Chuangpeng Lin; Tongyang Li; Guanyang Zou; Xudong Li; Li Ling; Wen Chen
Journal:  Front Public Health       Date:  2022-07-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.